BEZZIO, Cristina
 Distribuzione geografica
Continente #
AS - Asia 1.159
NA - Nord America 808
SA - Sud America 219
EU - Europa 207
AF - Africa 27
OC - Oceania 2
Totale 2.422
Nazione #
US - Stati Uniti d'America 770
SG - Singapore 704
CN - Cina 190
BR - Brasile 174
VN - Vietnam 119
HK - Hong Kong 39
IT - Italia 39
DE - Germania 35
FR - Francia 30
IN - India 30
MX - Messico 19
BD - Bangladesh 17
GB - Regno Unito 17
CA - Canada 15
AR - Argentina 13
IE - Irlanda 13
EC - Ecuador 12
FI - Finlandia 12
RU - Federazione Russa 12
NL - Olanda 9
ES - Italia 8
ZA - Sudafrica 8
AT - Austria 6
PK - Pakistan 6
TR - Turchia 6
CO - Colombia 5
IQ - Iraq 5
LT - Lituania 5
PE - Perù 5
PL - Polonia 5
ID - Indonesia 4
JO - Giordania 4
JP - Giappone 4
NP - Nepal 4
PY - Paraguay 4
SA - Arabia Saudita 4
CL - Cile 3
CZ - Repubblica Ceca 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
LV - Lettonia 3
MA - Marocco 3
NG - Nigeria 3
PS - Palestinian Territory 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CI - Costa d'Avorio 2
EG - Egitto 2
KG - Kirghizistan 2
KZ - Kazakistan 2
SE - Svezia 2
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LU - Lussemburgo 1
ML - Mali 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
TV - Tuvalu 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.422
Città #
Singapore 301
Ashburn 164
San Jose 127
The Dalles 104
Shanghai 57
Beijing 46
Chandler 43
Ho Chi Minh City 37
Hong Kong 36
Dallas 34
Hanoi 29
Los Angeles 22
Boardman 20
Milan 20
Santa Clara 17
São Paulo 14
Dublin 13
Helsinki 12
Mexico City 12
New York 11
Montreal 9
Secaucus 9
Chennai 8
Düsseldorf 8
Lawrence 8
Princeton 8
Brooklyn 7
Buffalo 7
Da Nang 7
Frankfurt am Main 7
Orem 7
Seattle 7
Amsterdam 6
London 6
Quito 6
Rio de Janeiro 5
Rome 5
Amman 4
Curitiba 4
Johannesburg 4
Munich 4
Paris 4
Porto Alegre 4
Portsmouth 4
San Francisco 4
Warsaw 4
Belo Horizonte 3
Benin City 3
Brasília 3
Chandigarh 3
Chicago 3
Council Bluffs 3
Dhaka 3
Guayaquil 3
Irsina 3
Lima 3
Limeira 3
Mumbai 3
Nairobi 3
Ninh Bình 3
Phoenix 3
São Bernardo do Campo 3
Taiyuan 3
Tashkent 3
Thái Bình 3
Tokyo 3
Toronto 3
Valencia 3
Abidjan 2
Asunción 2
Atlanta 2
Bishkek 2
Boston 2
Bruino 2
Brussels 2
Campinas 2
Caxias do Sul 2
Concord 2
Cuiabá 2
Falkenstein 2
Fortaleza 2
Foz do Iguaçu 2
Guarulhos 2
Hai Bà Trưng 2
Hillsboro 2
Houston 2
Itabira 2
Jacksonville 2
Jeddah 2
Lambaré 2
Lauterbourg 2
Madrid 2
Manaus 2
Marseille 2
Moscow 2
New Delhi 2
Petrópolis 2
Pinhais 2
Prague 2
Pune 2
Totale 1.405
Nome #
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 95
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors 85
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 67
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 60
Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication 60
Dietary Fiber in Inflammatory Bowel Disease: Are We Ready to Change the Paradigm? 59
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 59
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study 56
The learning curve for using intestinal ultrasonography 54
The Impact of Ustekinumab Biosimilar on Therapeutic Strategies in Crohn's Disease: A Paradigm Shift? 51
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 50
Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative review 50
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study 49
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy 47
Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study 47
Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease 47
Efficacy of a novel self-assembling peptide hemostatic gel as rescue therapy for refractory acute gastrointestinal bleeding 47
Nutritional care at centres managing patients with inflammatory bowel disease: A nationwide survey in Italy 45
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 45
Reporting of Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Italian Survey 45
Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease 44
Hold the Foam : Why Topical Budesonide Remains Relevant for IBD Therapy 44
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 43
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 43
Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections 42
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study 42
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 42
Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons 41
Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease 41
Efficacy, safety and tolerability, the imperfect triangle arising from the new low volume colon preparations 40
Planning phase two for endoscopic units in Northern Italy after the COVID-19 lockdown: An exit strategy with a lot of critical issues and a few opportunities 40
Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It 40
IBD Flare in the COVID-19 Pandemic:Therapy Discontinuation Is to Blame 39
Endoscopic ultrasound-guided gallbladder drainage in pancreatic cancer and cholangitis: A case report 39
Prevalence, Risk Factors and Association with Clinical Outcomes of Malnutrition and Sarcopenia in Inflammatory Bowel Disease: A Prospective Study 38
Impact of histologic disease activity on long-term outcomes in patients with ileal pouch-anal anastomosis for ulcerative colitis 37
Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review 37
Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms in Northern Italy: A Single-Center Cohort Study 36
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 36
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study 36
Gastrointestinal ultrasound in inflammatory bowel disease: Seeing beyond limits 36
Management of proctitis in ulcerative colitis and the place of biological therapies 35
Improvement in appropriateness and diagnostic yield of fast-track endoscopy during the COVID-19 pandemic in Northern Italy 34
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 34
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy 34
Does ProCore fine needle biopsy really improve the clinical outcome of endoscopic ultrasound-guided sampling of pancreatic masses? 33
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey 32
Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds 31
Ulcerative Colitis : not only gut 31
Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist 31
Management of Post-Operative Crohn’s Disease: Knowns and Unknowns 30
Neuroendocrine tumors in patients with inflammatory bowel disease: a case series 29
Collecting and Analyzing IBD Clinical Data for Machine-Learning: Insights from an Italian Cohort 27
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 27
Inflammatory bowel disease in a colorectal cancer screening population: Diagnosis and follow-up 26
Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies 25
Upadacitinib in Patients With Difficult-to-Treat Crohn’s Disease 22
Proposal for returning to routine endoscopy during the COVID-19 pandemic: what is really feasible? 22
Combining Advanced Targeted Therapy in Inflammatory Bowel Disease: Current Practice and Future Directions 11
Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) survey 9
A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting 8
Totale 2.485
Categoria #
all - tutte 12.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 0 1
2021/20226 0 0 0 1 0 0 0 0 1 0 3 1
2022/2023107 17 2 9 16 8 13 0 7 16 10 7 2
2023/2024156 3 7 20 5 2 5 8 4 0 34 29 39
2024/2025703 6 7 20 15 6 43 46 66 125 164 100 105
2025/20261.509 217 90 68 153 118 117 442 88 133 83 0 0
Totale 2.485